Mechanical circulatory assist devices are now commonly used in the treatment of severe
heart failure as bridges to cardiac transplant, as destination therapy for patients who are not …

De novo progressive aortic insufficiency (AI) is a side effect frequently related to prolonged
support with continuous-flow left ventricular assist devices (CF-LVAD). Its progression can …

Objectives: This study sought to evaluate the impact of moderate to severe aortic
insufficiency (AI) on outcomes in patients with continuous flow left ventricular assist devices …

Background Preexisting valve pathology is common in patients with end-stage heart failure
undergoing left ventricular assist device (LVAD) placement. The indications and subsequent …

Mechanical circulatory support has seen numerous advances in the recent years, with
important observations made to guide patient selection for the therapy, indications for use …

Objective Increased use of continuous-flow left ventricular assist devices for long-term
mechanical support necessitates a better understanding of hemodynamic changes in the …

Background Aortic insufficiency (AI) is a significant long-term complication of continuous-
flow left ventricular assist device (CF-LVAD) implantation. We sought to evaluate its impact …

Initiation of LVAD support may exacerbate preexisting AI via the mechanisms highlighted
above. 9, 12 An incompetent AV can lead to a closed loop with blood flowing from the LV …

Aortic insufficiency (AI) may occur while supported on a left ventricular assist device (LVAD).
We conducted a systematic review to determine the incidence, predictors, and …

Abstract More than 2,400 continuous-flow left ventricular assist devices (LVADs) are
implanted each year in the United States alone. Both the number of patients living with …